Literature DB >> 34687440

Pharmacology of Diosmin, a Citrus Flavone Glycoside: An Updated Review.

Samar H Gerges1, Sara A Wahdan1, Doaa A Elsherbiny1, Ebtehal El-Demerdash2.   

Abstract

Flavonoids are phytochemicals that are well known for their beneficial pharmacological properties. Diosmin is a flavone glycoside derived from hesperidin, a flavanone abundantly found in citrus fruits. Daflon is an oral phlebotonic flavonoid combination containing diosmin and hesperidin (9:1) that is commonly used for the management of blood vessel disorders. After oral administration, diosmin is converted to diosmetin, which is subsequently absorbed and esterified into glucuronide conjugates that are excreted in the urine. Pharmacological effects of diosmin have been investigated in several in vitro and in vivo studies, and it was found to possess anti-inflammatory, antioxidant, antidiabetic, antihyperlipidemic, and antifibrotic effects in different disease models. Diosmin also demonstrated multiple desirable properties in several clinical studies. Moreover, toxicological studies showed that diosmin has a favorable safety profile. Accordingly, diosmin is a potential effective and safe treatment for many diseases. However, diosmin exhibits inhibitory effects on different metabolic enzymes. This encourages the investigation of its potential therapeutic effect and safety in different diseases in clinical trials, while taking potential interactions into consideration.
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34687440     DOI: 10.1007/s13318-021-00731-y

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  65 in total

Review 1.  Micronised purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids.

Authors:  Katherine A Lyseng-Williamson; Caroline M Perry
Journal:  Drugs       Date:  2003       Impact factor: 9.546

2.  Structure-antioxidant activity relationships of flavonoids and phenolic acids.

Authors:  C A Rice-Evans; N J Miller; G Paganga
Journal:  Free Radic Biol Med       Date:  1996       Impact factor: 7.376

3.  Clinical acceptability study of micronized purified flavonoid fraction 1000 mg tablets versus 500 mg tablets in patients suffering acute hemorrhoidal disease.

Authors:  Yuri Shelygin; Zoran Krivokapic; S A Frolov; I V Kostarev; V L Astashov; S V Vasiliev; A V Lakhin; G V Rodoman; A O Soloviev; Y M Stoyko; A G Khitaryan; I A Nechay
Journal:  Curr Med Res Opin       Date:  2016-08-25       Impact factor: 2.580

Review 4.  Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).

Authors:  Ronald Bush; Anthony Comerota; Mark Meissner; Joseph D Raffetto; Steven R Hahn; Katherine Freeman
Journal:  Phlebology       Date:  2017-04       Impact factor: 1.740

5.  Effects of micronised purified flavonoid fraction on pain, semen analysis and scrotal color Doppler parameters in patients with painful varicocele; results of a randomized placebo-controlled study.

Authors:  Haluk Söylemez; Süleyman Kiliç; Murat Atar; Necmettin Penbegül; Ahmet Ali Sancaktutar; Yaşar Bozkurt
Journal:  Int Urol Nephrol       Date:  2011-07-30       Impact factor: 2.370

6.  Protective effect of diosmin against diabetic neuropathy in experimental rats.

Authors:  Dilpesh Jain; Manish Kumar Bansal; Rahul Dalvi; Aman Upganlawar; Rahul Somani
Journal:  J Integr Med       Date:  2014-01

7.  Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease.

Authors:  O C Meyer
Journal:  Angiology       Date:  1994-06       Impact factor: 3.619

8.  Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy.

Authors:  Sahabuddin Ahmed; Nitin Mundhe; Manash Borgohain; Liakat Chowdhury; Mohit Kwatra; Nityanand Bolshette; Anwaruddin Ahmed; Mangala Lahkar
Journal:  Inflammation       Date:  2016-10       Impact factor: 4.092

9.  Simultaneous determination of diosmin and diosmetin in human plasma by ion trap liquid chromatography-atmospheric pressure chemical ionization tandem mass spectrometry: Application to a clinical pharmacokinetic study.

Authors:  Miguel Angel Campanero; Manuel Escolar; Guiomar Perez; Emilio Garcia-Quetglas; Belen Sadaba; Jose Ramon Azanza
Journal:  J Pharm Biomed Anal       Date:  2009-09-12       Impact factor: 3.935

10.  Medicamentous treatment of chronic venous insufficiency using semisynthetic diosmin--a prospective study.

Authors:  Z V Maksimović; M Maksimović; D Jadranin; I Kuzmanović; O Andonović
Journal:  Acta Chir Iugosl       Date:  2008
View more
  5 in total

1.  Antioxidant, Antihypertensive, Hypoglycaemic and Nootropic Activity of a Polyphenolic Extract from the Halophyte Ice Plant (Mesembryanthemum crystallinum).

Authors:  Marta María Calvo; Ana Belén Martín-Diana; Daniel Rico; María Elvira López-Caballero; Oscar Martínez-Álvarez
Journal:  Foods       Date:  2022-05-27

Review 2.  Potential and Therapeutic Roles of Diosmin in Human Diseases.

Authors:  Etimad Huwait; Mohammad Mobashir
Journal:  Biomedicines       Date:  2022-05-06

3.  Flavonoids: Antiplatelet Effect as Inhibitors of COX-1.

Authors:  Cristina Zaragozá; Miguel Ángel Álvarez-Mon; Francisco Zaragozá; Lucinda Villaescusa
Journal:  Molecules       Date:  2022-02-08       Impact factor: 4.411

4.  Mechanistic Insight into Diosmin-Induced Neuroprotection and Memory Improvement in Intracerebroventricular-Quinolinic Acid Rat Model: Resurrection of Mitochondrial Functions and Antioxidants.

Authors:  Mian Huang; Navpreet Singh; Ritu Kainth; Mohammad Khalid; Ajay Singh Kushwah; Manish Kumar
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-08       Impact factor: 2.629

Review 5.  Oligomeropathies, inflammation and prion protein binding.

Authors:  Gianluigi Forloni; Pietro La Vitola; Claudia Balducci
Journal:  Front Neurosci       Date:  2022-08-23       Impact factor: 5.152

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.